Navigation Links
Tysabri May Treat Myelin Sheath Damage From MS

Drug makers' study finds therapy has capacity to repair nerve fiber damage

TUESDAY, April 28 (HealthDay News) -- The drug Tysabri (natalizumab) appears to regenerate and stabilize damage done to the myelin sheath in people with multiple sclerosis (MS), a study from drug makers Biogen Idec and Elan Corp shows.

MS is nervous system disease that affects the brain and spinal cord. Symptoms experienced by MS patients are caused by damage to the myelin sheath that surrounds and protects nerve cells.

In this study, researchers used advanced MRI technology to measure lesions and normal brain tissue in patients who took either Tysabri, interferon beta-1a, or no drugs. After 12 months of follow-up, the 62 patients who took Tysabri showed remyelination when compared to the 26 who took inteferon beta-1a or the 22 patients in the control group.

The findings were presented Tuesday at the annual meeting of the American Academy of Neurology, in Seattle.

"What we have seen in these MRI data suggest that Tysabri may have the capacity to repair and possibly restore some of the damaged myelin sheath that protects nerve fibers. Results from this study support the continued investigation of the potential effects of Tysabri on this process," lead investigator Dr. Robert Zivadinov, of the Jacobs Neurological Institute in Buffalo, N.Y., said in a news release.

Tysabri is approved for treatment of relapsing forms of MS in the United States and for relapsing-remitting MS in the European Union.

More information

The National Multiple Sclerosis Society has more about MS treatments.

-- Robert Preidt

SOURCE: American Academy of Neurology, news release, April 28, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Stopping Tysabri May Worsen MS
2. MS Drug Tysabri Approved for Crohns Disease
3. Tysabri May Cause Liver Damage, Health Officials Say
4. Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects
5. Using coxibs and NSAIDs to treat osteoarthritis
6. New treatment effective in counteracting cocaine-induced symptoms
7. New treatment boosts muscle function in myasthenia gravis
8. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
9. Free distribution of insecticide-treated mosquito nets can save lives
10. Kenyan malaria success strengthens call for free insecticide-treated nets for all
11. Broad-based group of physicians calls for improvement in stroke treatment
Post Your Comments:
Related Image:
Tysabri  May Treat Myelin Sheath Damage From  MS
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology: